While protein growth factors promote therapeutic angiogenesis, delivery of lipid factors such as sphingosine 1-phosphate (S1P) may provide better stabilization of newly formed vessels. We developed a biomaterial for the controlled delivery of S1P, a bioactive lipid released from activated platelets. Multi-arm poly(ethylene glycol)-vinyl sulfone was crosslinked with albumin, a lipidtransporting protein, to form hydrogels. The rate of S1P release from the materials followed Fickian kinetics and was dependent upon the presence of lipid carriers in the release solution. Delivery of S1P from RGD-modified hydrogels increased the cell migration speed of endothelial cells growing on the materials. The materials also induced angiogenesis in the chorioallantoic membrane assay. Our data demonstrate that the storage and release of lipid factors provides a new route for the induction of angiogenesis by artificial materials. of newly formed vessels, 2,24,25 suggests that delivery of S1P from materials may provide a more effective route for the formation of a mature vasculature.
Introduction
Angiogenesis is necessary to restore the blood supply to ischemic tissue and to generate complex engineered tissues. The formation of new blood vessels is a multistep process, occurring primarily at sites of vascular injury in adults, mediated by the temporally-controlled release of biological factors. 1 Many of the factors that control angiogenesis are released from activated platelets, including platelet derived growth factor (PDGF), 2 vascular endothelial growth factor (VEGF), 3 and basic fibroblast growth factor (bFGF), 4,5 as well as lipid factors such as sphingosine 1-phosphate (S1P) and lysophosphatidic acid. 6,7 During angiogenesis, endothelial cells are initially stimulated to weaken cell-cell interactions, which increases vascular permeability. 8, 9 Endothelial cells then proliferate and migrate through the subendothelial matrix, forming sprouts from the wall of the original vessel. 10 These sprouts develop into tube structures 11 that are stabilized by the recruitment of mural cells to the outer surface of the tube of endothelial cells. 6
Although delivery of bFGF and VEGF to tissues can promote angiogenesis, 12-14 the newly formed vessels may regress over time. 15,16 S1P has been reported to be a complete angiogenic factor, 17-19 regulating early stages of angiogenesis by promoting endothelial cell migration and proliferation, 20,21 and later stages by stimulating endothelial cell entubulation 22 and directing the stabilization of newly formed vessels. 23,24 Knockout of the major endothelial cell S1P receptor, S1P 1 , is lethal in mice at E12.5-14.5 due to incomplete vessel maturation, implying a role for S1P in recruiting mural cells, either directly or indirectly. 25 The ability of S1P to stimulate multiple steps in angiogenesis, 17, 19 including the stabilization and maturation ppm (t, 2H, -SO 2 CH 2 CH 2 OH). In the final step, the hydroxyethylsulfone was converted to a vinyl sulfone. PEG-hydroxyethylsulfone (7.97 g) was dried by azeotropic distillation in toluene until the final volume was 150 mL. After cooling, 50 mL DCM was added to prevent precipitation of the PEG. The solution was cooled on ice for 15 min, then 2.68 mL TEA (3 equiv.) was added. Next, 0.75 mL mesyl chloride (1.5 equiv.) was added dropwise, and the solution was allowed to react for 24 h. Another 2.68 mL TEA (3 equiv.) was added, followed by 0.75 mL mesyl chloride (1.5 equiv. added dropwise), and the reaction was carried out overnight. The TEA salt was filtered out and the total volume was reduced to approx. 20 mL by rotary evaporation. PEG was precipitated by addition of ice-cold diethyl ether, recovered by filtration, and dried under vacuum: 1 H NMR (CDCl 3 ) 3.61 ppm (PEG backbone), 6.04 ppm (d, 1H, =CH 2 ), 6.35 ppm (d, 1H, =CH 2 ), 6.79 ppm (q, 1H, -SO 2 CH=). PEG-tetravinyl sulfone (PEG-TVS) was synthesized from four-arm PEG (mol. wt. 10,000, Shearwater Polymers) using the same protocol with 80% end group conversion by NMR. PEG-diamine was synthesized as previously described 32 from poly(ethylene glycol), mol. wt. 3400 (24 g, Sigma, St. Louis, MO, USA): 1 H NMR (CDCl3) 2.85 ppm (t, 4H, -CH 2 -NH 2 ), 3.65 ppm (PEG backbone). End group conversion was 99.1% as shown by NMR.
Hydrogel Formation
Hydrogels were formed by a conjugate addition reaction between PEG-OVS and: (1) PEGdiamine, (2) fatty acid-free bovine serum albumin (FAF-BSA), (3) bovine fibrinogen, or (4) dithiothreitol (DTT). DTT was dissolved in phosphate buffered saline (PBS; 137 mM NaCl, 8 mM Na 2 HPO 4 ·7H 2 O, 0.7 mM CaCl 2 , 2.7 mM KCl, 1.5 mM KH 2 PO 4 , 0.5 mM MgCl 2 ; pH 7.4) at 0.3 mg per 10 μL PBS. All other precursors were dissolved in PBS by adding 10 mg solid to 50 μL PBS at pH 8.0 (assuming a volume change due to the dissolved precursors to be 1 μL per mg of solid, the precursors were nominally dissolved at 10 mg/60 μL). PEG-OVS was then mixed with crosslinking molecules at a 1:1 ratio of vinyl sulfone to amine. For albumin and fibrinogen, this ratio was estimated by analyzing the 3D crystal structures of the proteins (Protein Databank IDs: 1AO6 and 1DEQ, respectively) with the Deep View Swiss-Pdb Viewer using the default accessibility option in the software. This analyzes lysines based on surface area solvent accessibility of the residue, but does not necessarily indicate the availability of the amine for reaction with a vinyl sulfone. For albumin, 36 of the 59 lysines were accessible, while for fibrinogen 65 of 106 were accessible. Optimal ratios of reactants were then determined empirically for each crosslinker by forming gels with different ratios of each component, seeking to minimize the amount of gel swelling in PBS after crosslinking. For PEG-OVS/PEG-diamine gels, 50 μL PEG-OVS (~8.3 mg) was mixed with 68 μL PEG-diamine (~11.3 mg). For PEG-OVS/albumin gels, the final mixture consisted of 40 μL PEG-OVS (~6.6 mg) and 60 μL albumin (~10.0 mg). For PEG-OVS/fibrinogen, the final ratio was 20 μL PEG-OVS (~3.3 mg) to 50 μL fibrinogen (~8.3 mg). After mixing the precursors, gels were formed in tissue culture plate wells, or, for thin layer chromatography, the scrape wound assay, or the chorioallantoic membrane assay, between glass microscope slides. For the latter method, the solution was pipetted onto the center of a glass microscope slide made hydrophobic with SigmaCote (Sigma, St. Louis, MO). Another hydrophobic slide was clamped on top, using 0.7 mm thick Teflon spacers at the edges of the slides. The solution contacted only hydrophobic glass and formed a circular disc. The solutions were crosslinked in a 37 °C humidified incubator for 24 h. The gels were then swollen in PBS overnight.
PEG hydrogel swelling
PEG hydrogels (50 μL) were formed using PEG-OVS and PEG-TVS crosslinked with albumin, fibrinogen, PEG-diamine, or DTT. The hydrogels were swollen in PBS for 96 h and each gel was weighed to determine the swollen volume. Densities used in the calculation of volume fractions were: PBS, 1.017 g/mL; PEG, 1.199 g/mL; albumin, 1.364 g/mL; fibrinogen, 1.379 g/mL; and DTT, 1.000 g/mL.
PEG hydrogel mesh size estimated using electrophoresis
A modified SDS-PAGE gel was used to characterize albumin diffusion through PEG hydrogels. A 15% acrylamide gel was formed at the bottom of the casting chamber, with a spacer to form a well on the left side of the gel. After the acrylamide solidified, the PEG-OVS/ albumin precursor solution was pipetted into the formed well. The casting stand was placed in a humidified 37 °C incubator for 24 h to crosslink the PEG gel. A 7% acrylamide gel was formed over the polymerized gels, followed by a stacking gel.
S1P loading
PEG hydrogels were loaded with S1P using two methods: 'postloading' and 'preloading'. PEG hydrogels were 'postloaded' with S1P by passive diffusion, incubating the formed gels with 500 μL 10 μM S1P (5 nmol) in PBS containing 0.01% (w/v) FAF-BSA. Following 24 h of incubation with S1P, gels were washed in PBS twice for 1 h and then once for 24 h. PEG hydrogels were 'preloaded' with S1P by reacting a solution of PEG-OVS with a solution containing a crosslinker premixed with 5 nmol S1P. S1P-preloaded gels were washed in PBS twice for 1 h and then once for 24 h.
Thin layer chromatography (TLC)
After washing in PBS, 150 μL S1P-loaded gels were placed into Eppendorf tubes containing 500 μL 0.4% FAF-BSA in PBS, which was vortexed for 24 h. A small sample of the PBS (5 μL) was removed from each Eppendorf tube and loaded on a silica TLC plate (Whatman, Inc., Clifton, New Jersey). The plates were developed in butanol:acetic acid:water (3:3:1). For visualization, the TLC plate was sprayed with ninhydrin reagent (0.2 g ninhydrin in 100 mL butanol) and heated.
[ 32 P]S1P Release
Radiolabeled S1P was produced using the methods of Olivera et al. 35 Briefly, 10 μl of 10 mM sphingosine (BioMol, Plymouth Meeting, PA) in buffer A (25 mM Tris HCl, pH 7.4, 10% (v/ v) glycerol, 0.05% Triton X-100, 1 mM DTT) containing 0.4% BSA was added to 80 μL sphingosine kinase (3.6 mg/mL in buffer A), and 90 μL buffer A. The reaction was started by adding 20 μL [ 32 P]ATP (100 μCi, 10 mM, MP Biomedicals, Irvine, CA) in 100 mM MgCl. The reaction was incubated overnight at 37 °C and stopped by the addition of 20 μL of 1 M HCl. Lipids were extracted with 800 μL chloroform/methanol/1 M HCl (100:200:1). After mixing, 240 μL chloroform and 240 μL 2 M KCl were added and the solution was centrifuged. The aqueous phase was removed, and the organic phase was extracted again by the addition of 400 μL 1:1 methanol/1 M HCl. The phases were separated by centrifugation. The organic phase was removed, dried under nitrogen flow, and dissolved in PBS containing FAF-BSA. For gels postloaded with S1P after crosslinking, [ 32 P]S1P was dissolved in PBS containing 0.01% FAF-BSA and added to 50 μL PEG hydrogels in a 24-well plate for 24 h. For gels formed from albumin preloaded with S1P, [ 32 P]S1P was dissolved in 570 μL PBS containing 95 mg FAF-BSA. Aliquots were mixed with PEG-OVS and incubated for 24 h to form S1Pcontaining hydrogels (50 μL total volume) on the bottoms of wells in a 24-well plate. The S1Ploaded hydrogels were washed twice in 1 mL PBS for 1 h (to remove unbound S1P) and a third time for 24 h. Next, 1.5 mL of platelet poor plasma (PPP) or PBS containing 0%, 0.4%, or 4% (w/v) FAF-BSA was added to the gels. The solutions were removed from the wells and replaced with fresh solutions at 1, 3, 6, 12, and 24 h and the release of [ 32 P]S1P was quantified by scintillation counting. The release at each time point is reported as a fraction of total S1P in each gel, which was determined by summing the amount of S1P in all wash and release solutions for each gel and the amount of S1P in each gel at the end of the experiment. PPP was obtained from human subjects with informed consent in accordance with Washington University Medical Center guidelines (Human Studies Committee Approval #04-097).
Cell culture
All cell culture reagents were purchased from Sigma (St. Louis, MO) unless otherwise noted. Human umbilical vein endothelial cells (HUVEC) were purchased from Clonetics, Inc (Walkersville, MD) and cultured in MCDB 131 medium supplemented with 2% FBS, 10 ng/ mL epidermal growth factor, 10 μg/mL heparin, 1.0 μg/mL hydrocortisone, 1% antibioticantimycotic (ABAM, 100x) solution (Invitrogen, Carlsbad, CA), and 6 mg/L bovine brain extract (Clonetics)
Scrape Wound Assay
Cells from passage 5-7 were grown to confluence in a 6-well tissue culture plate and then switched to low serum medium (LSM; 0.1% FBS, 1% ABAM in MCDB 131 medium) with 10 ng/mL VEGF and 0.4% FAF-BSA 12 h prior to the start of the experiment (the VEGF was added to enhance survival of cells at 24 h associated with low serum medium). A 1000 μL pipette tip was used to make a vertical and a horizontal scrape wound in each well, crossing near the middle of the well. Each well was washed 3x with PBS to remove non-adherent cells. At the start of the experiment, pictures were taken at 4x magnification on each arm of the scrape wound and 20 μL PEG gels were then added to the appropriate wells. Pictures were taken again after 24 h, using calipers on the microscope to locate the same locations. Image-Pro Express software was used to define the initial scrape wound area and the number of cells within the wound area was counted manually.
Chorioallantoic Membrane (CAM) Assay
Embryonated chicken eggs were incubated blunt-end up in a 37°C incubator. At embryonal day 6, the top of the egg was cracked and removed using tweezers to create a 1.5 cm diameter opening. The inner shell membrane was removed, exposing the CAM. A 20 μL PEG hydrogel was then placed onto the CAM. As controls, 50 ng bFGF or 50 ng S1P were spotted onto small pieces of Thermanox coverslips (Nunc), air dried and placed onto the CAM. The eggs were sealed with parafilm and returned to the incubator. After two days of incubation, the eggs were reopened and the degree of angiogenesis was visually assessed. 36
Sulforhodamine Release
Sulforhodamine B (500 nmol) was preloaded into gels formed with PEG-OVS crosslinked with albumin, PEG-diamine, or DTT. The release experiment was run using the same protocol as the [ 32 P]S1P release experiments described above, with detection by visible light spectroscopy at 554 nm.
Individual Cell Tracking
PEG-OVS (3.4 mg in 20 μL) was reacted for 30 min with acetyl-GCGYGRGDSPG-NH 2 peptide, to attach the peptide to 1/20 of the vinyl sulfone groups (2.78 mM RGD peptide in the final hydrogel). The PEG hydrogels were crosslinked by reacting PEG-OVS with albumin (5.2 mg in 30 μL) premixed with S1P (5 nmol) to give a final concentration of 100 μM S1P within the crosslinked hydrogel. The resulting solution (50 μL) was pipetted into a 24-well plate and incubated at 37 °C for 24 h to allow crosslinking. HUVEC from passage 5-7 were seeded onto the gels at a concentration of 1000 cell/cm 2 . After allowing the cells to spread for 6 h in complete growth medium, HEPES-buffered low serum medium (MCDB 131 with 0.1% FBS, 1% ABAM, 10 μM HEPES, pH 7.4) containing 0.4% FAF-BSA was added to the cells. The cells were tracked using time-lapse microscopy for 12 h, recording images every two minutes. Individual cell migration speeds were analyzed manually using ImageJ to trace the path of each cell over time. The time increment between analysis was increased to six minutes if cells maintained a straight path in the three consecutive images.
Results

PEG gel formation and characterization
We synthesized PEG-OVS using a four step method, based on the methods of Morpurgo et al. 34 Each step of the synthesis gave about an 80% yield of product, and the extent of endgroup modifications were measured using NMR following each step ( Fig. 1a ). NMR on the final product, PEG-OVS, showed 74.7% endgroup conversion to vinyl sulfone ( Fig. 1b) , with 18.8% of the endgroups present as mesylates. Considering that conversion to the hydroxymethyl sulfide was only 80% complete, it is likely that the mesylates are attached to carbons that are beta to ether groups, not sulfones. Thus, the product is only nominally octavinyl sulfone, with typically 6 vinyl sulfones and 1-2 mesylate groups per polymer chain. The mesylates may hydrolyze before reaction or may contribute to the crosslinking reaction.
PEG-OVS was crosslinked with molecules containing two or more thiols or amines, forming hydrogels via conjugate addition reactions (i.e. Michael-type addition). At 37 °C, PEG-OVS formed a gel with a thiol crosslinker, DTT, in less than 10 min (at pH 7.4) and with amine crosslinkers in approximately 16 h (at pH 8.5). The swelling properties of the hydrogels were determined for the different crosslinkers. Gels crosslinked with proteins swelled less than gels crosslinked with bifunctional crosslinkers, indicating that at least some of the protein molecules served as elastically-active crosslink sites ( Fig. 2a ). Additionally, PEG-OVS/albumin hydrogels swelled less than PEG-OVS/fibrinogen hydrogels. PEG-OVS/albumin gels were exceptional in that they did not appreciably swell or shrink from the volume at which they were crosslinked. This property allowed us to covalent couple these hydrogels to surfaces during crosslinking, leading to gels whose surfaces did not appreciably deform following addition to excess solvent. Typically, gels attached to surfaces during crosslinking will wrinkle or tear while reaching equilibrium swelling volumes.
The mesh size of PEG-OVS/albumin hydrogels was investigated using SDS-PAGE with a PEG-OVS/albumin hydrogel polymerized into the acrylamide gel. Albumin migration through the PEG gel was hindered, resulting in an accumulation of albumin above the PEG layer ( Fig.  2c) . Thus, the mesh size of the hydrogels, which is characterized by the radius of gyration of the polymer chains between elastically-active crosslinks, is less than or on the order of the radius of gyration of albumin (about 30 Å). 37 The molecular weight markers aprotinin (6.5 kDa) and lysozyme (14.4 kDa) freely passed through the PEG gel (data not shown).
Loading PEG hydrogels with S1P
S1P was loaded into the PEG hydrogels using two techniques, postloading and preloading. For postloading, previously formed PEG hydrogels were placed in solutions containing S1P and 0.01% (w/v) FAF-BSA. The FAF-BSA in solution was necessary to solubilize the S1P, but the concentration of albumin in the loading solution was much lower than the concentration of albumin in the hydrogel (10% w/v). For preloading, S1P was solubilized directly into the albumin solution used to crosslink the PEG-OVS. After S1P loading, the gels were washed with PBS three times over 26 h to remove weakly-bound S1P, unbound S1P or S1P attached to albumin molecules that were not crosslinked within the gel.
PEG gels postloaded with S1P
Thin layer chromatography was used to analyze the release of S1P from postloaded hydrogels. Most of the S1P was washed out of PEG-OVS/PEG-diamine hydrogels in the first 1 h wash with PBS, but PEG-OVS/albumin hydrogels retained the S1P during the washes (Fig. 3a) . When the hydrogels were placed into a solution containing 0.4% FAF-BSA, a large amount of S1P was released from the PEG-OVS/albumin hydrogels, but apparently little of the S1P remained in the PEG-OVS/PEG-diamine hydrogels to be released (Fig. 3b ).
We produced 32 P-radiolabeled S1P to quantify loading and release of S1P with postloaded PEG-OVS/albumin hydrogels. [ 32 P]S1P (5 nmol in 1.5 mL) was dissolved in PBS containing 0.01% FAF-BSA and incubated with 50 μL hydrogels formed in the bottoms of wells of a 24well tissue culture plate. When PEG-OVS/albumin hydrogels were incubated with 1.5 mL of the 3.33 μM S1P solution, 59.1 ± 3.1% of the [ 32 P]S1P in solution was captured in the gel within 24 h. The gels were then washed thoroughly with PBS for 26 h, with 6.9 ± 1.1% of the loaded S1P released into the wash solutions. PBS containing 0.4% FAF-BSA was added to the gels and controlled release of S1P from the gels was observed, with 46.6 ± 0.4% of the remaining S1P released over 24 h (Fig. 3c ).
An in vitro scrape wound assay 38 was used to demonstrate that S1P released from postloaded gels promoted endothelial cell migration. S1P-loaded PEG gels were placed into tissue culture wells containing scrape-wounded HUVEC in low serum medium supplemented with 10 ng/ mL VEGF and 0.4% w/v FAF-BSA. The hydrogels were allowed to freely float in the medium. PEG-OVS/albumin gels postloaded with S1P significantly increased the number of endothelial cells that migrated into the scrape wound area by 24 h, compared to wells without gels, gels not loaded with S1P, or PEG-OVS/fibrinogen or PEG-OVS/PEG-diamine hydrogels postloaded with S1P ( Fig. 4 ). Considering the results in Fig. 3a , the S1P loaded in the fibrinogen and diamine crosslinked hydrogels was likely removed during the washing steps.
A chick CAM assay was used to demonstrate the ability of S1P-releasing hydrogels to induce angiogenesis in vivo. PEG hydrogels were placed onto the CAM on embryonic day 6 and the extent of the angiogenic response was determined two days later. As controls, bFGF or S1P were spotted on Thermonox coverslips, eliciting a strong angiogenic response (Fig. 5a ). PEG-OVS/albumin gels not loaded with S1P did not induce an angiogenic response, while PEG-OVS/PEG-diamine gels postloaded with S1P and washed with PBS for 26 h exhibited at most a modest angiogenic response. However, PEG-OVS/albumin hydrogels postloaded with S1P induced a moderate to strong angiogenic response (Fig. 5b) . Two independent replicates are shown for each condition.
PEG gels preloaded with S1P
Release of S1P from preloaded PEG-OVS/albumin hydrogels was quantified using [ 32 P]S1P. The hydrogels were formed in the bottoms of the wells of a 24-well plate. The formed gels were washed with PBS over 26 h and then incubated with solutions containing different concentrations of albumin in PBS. S1P release into PBS alone was limited, while the rate of release increased with higher concentrations of albumin in solution ( Fig. 6a) . Controlled release was observed, with 33.8 ± 1.5% of the S1P remaining in the gel after washing released into 4% FAF-BSA in 24 h, and 26.0 ± 0.5% of the S1P released into 0.4% FAF-BSA in 24 h. S1P release into human platelet poor plasma, which contains approximately 4% albumin, displayed release kinetics similar to 0.4% FAF-BSA in PBS. This may be due to competition of S1P released from the hydrogels with lipids already bound to albumin and lipoproteins in plasma.
The effect of gel mesh size on the diffusion of small molecules was tested using a water-soluble dye molecule, sulforhodamine B. The dye was preloaded into PEG-OVS/albumin hydrogels and released into PBS. The molecular weight of sulforhodamine is 580.7, compared to 379.5 for S1P, and the diffusivity of the dye would be expected to be lower than that of S1P. Using the Wilke-Chang correlation (see Supplementary Materials) , we calculated a diffusion coefficient of 3.42 × 10 −6 cm 2 /sec for sulforhodamine and 4.15 × 10 −6 cm 2 /sec for S1P, both at 37 °C. Release of sulforhodamine B from the hydrogels was rapid, nearing completion in 6 h (Fig. 6c) , indicating that the mesh size of the PEG-OVS/albumin gels does not greatly affect the release of small molecules.
We used time-lapse microscopy to quantify endothelial cell migration speeds on PEG-OVS/ albumin hydrogels containing RGD peptide and preloaded with S1P. RGD peptide was added to the PEG hydrogels to promote endothelial cell adhesion and spreading on the materials. After endothelial cells were seeded on the gels, the gels were incubated with complete medium for 6 h containing 2% serum (with a total albumin concentration of about 0.08%). Over the next 12 h, cell migration rates were measured in low serum medium containing 0.4% FAF-BSA. Based on release between 32 h and 44 h in Fig. 6a , the S1P concentration in the low serum medium increased from less than 1 nM (low serum medium contained 0.1% FBS, and FBS contains 142 nM S1P 28 ) to at least 303 nM by the end of the migration experiment. Cell migration speeds were measured for HUVEC on 50 μL PEG/albumin/RGD hydrogels formed on the bottoms of wells of a 24-well tissue culture plate. Delivery of S1P from the hydrogels increased the mean migration speeds of HUVEC from 19.2 ± 10.1 μm/h to 43.8 ± 15.7 μm/h (Fig. 7) . The addition of culture medium containing 100 nM S1P increased the mean migration speed to only 30.2 ± 11.8 μm/h.
Analysis of S1P release data
An equilibrium binding constant for the interaction between S1P and albumin has not been reported. Additionally, reported values for equilibrium binding constants for interactions between lipids and proteins often vary by an order of magnitude. 39 The albumin concentration in each PEG-OVS/albumin gel was 1.51 mM (76 nmol in 50 μL) and the initial S1P concentration in the preloaded gels was 100 μM (5 nmol). The concentration of albumin in the 0.4% FAF-BSA release solution was 60.2 μM (75.8 nmol in 1.5 mL). Assuming equilibrium dissociation constants ranging from 1 nM to 10 μM, we determined that S1P release from the gels did not reach equilibrium at any of the experimental timepoints in 0.4% FAF-BSA, 4% FAF-BSA or PPP (see Supplementary Materials) . This indicated that S1P release was controlled by the rate of diffusion of S1P within the gel or the rate of diffusion of dissolved albumin into the gel, and not by the saturation of albumin in the release solutions with S1P.
The S1P release data were well-described by Fickian release kinetics, given by: [1] where t is the time from the start of the release experiment, m t is the mass of S1P released up to time t, m ∞ is the mass of S1P ultimately released at infinite time, D is an effective diffusion coefficient, and b is the thickness of the gel. 40,41 A single parameter, the effective diffusion coefficient D, was adjusted to least-squares fit the release data ( Fig. 6a ), considering only the first 100 terms of the infinite series and implicitly assuming that the release solution served as a perfect sink. The effective diffusion coefficients are listed in Table 1 .
For short time points (corresponding to less than 60% release), Fickian diffusional release from a thin polymer film can be estimated by: [2] The release data were described as a function of the square root of time and fit by linear regression (Fig. 6b ). The coefficients of determination obtained from the linear regressions are listed in Table 1 .
The equilibrium affinity constants should be determinable from our experimental system by analysis of S1P release from preloaded gels into PBS or the long-time partitioning of S1P into the gel during postloading. However, these methods would be complicated by the slow release of small amounts of unreacted albumin from the gel (see Fig. 2b ). Considering the release of S1P from preloaded gels into the PBS washes, the largest fractional release was observed in the first 1 h PBS wash (3.28%), which was more than double that observed with the 0% FAF-BSA wash (i.e. PBS) between 38 and 50 h (1.45%). Using the fractional release into 0% FAF-BSA between 38 and 50 h as an estimate of equilibrium release led to K D = 792 nM. Further analysis of the effects of K D on loading and release of S1P is found in Supplementary Table  1 .
Discussion
Materials that promote angiogenesis are desirable for treatment of myocardial and peripheral ischemia. A variety of methods of inducing angiogenesis have been explored, including gene therapy, 42 delivery of angiogenic proteins, 43 and angiogenic-potentiated cell transplants. 44, 45 The protein growth factors bFGF and VEGF are the most widely studied angiogenic stimulants. Studies using both of these growth factors have demonstrated induction of in vivo angiogenesis. 14, 31, [46] [47] [48] Initial clinical trials also demonstrated an increase in vascularization. 49-51 However, longer term clinical studies have shown that newly formed vessels may be unstable, leading to disintegration and little long-term improvement of function. 15,52-55 The long-term failure of therapeutic vascularization is likely due to the rapid depletion of angiogenic factors or the lack of recruitment of mural cells to stabilize the new vessels. With numerous studies reporting this loss of functional vessels after initial vascularization, it is apparent that delivery of factors other than bFGF and VEGF will be necessary to stabilize new vessels. 16 PDGF is one factor that promotes vessel stabilization. Studies utilizing the delivery of multiple growth factors, such as bFGF or VEGF to promote new vessels and PDGF to promote vessel stabilization, have demonstrated an increase in mature vasculature in animal models. 56, 57 Lipid factors such as S1P and lysophosphatidic acid are capable of inducing many events in angiogenesis. 17, 19 The primary receptor for S1P (S1P 1 ) has been known to be upregulated in endothelial cells in an angiogenic phenotype since 1990. 58 However, it was only in 1998 that S1P was demonstrated to be the ligand for this G protein-coupled receptor. 59 In particular, S1P is vital to the stabilization of vessels following angiogenesis. 24,60,61 Knockout of S1P 1 is embryonic lethal in mice, due to improper vessel maturation. 25 Since S1P is capable of promoting the earlier steps of angiogenesis, such as endothelial cell migration, 20,27,62 proliferation, 18 and entubulation, 17,19,22 as well as the later steps of vessel maturation, it may be more effective to deliver S1P than combinations of protein growth factors. Furthermore, many studies have found that S1P also serves to protect myocardial cells from cell death induced by ischemia. [63] [64] [65] [66] We demonstrated that the interaction of S1P with albumin immobilized in our materials is necessary to control the rate of S1P release from the PEG hydrogels. However, the specific manner in which the release is controlled is still unknown. Our experiments using 0%, 0.4%, or 4% (w/v) FAF-BSA solutions demonstrated that the concentration of albumin in solution impacts the rate of S1P release. We used S1P release into PPP to simulate release into blood in the body, which has a normal albumin range of 3.5-4.6 g/dL (3.5-4.6% (w/v)). 67,68 Although 4% albumin is within the normal concentration range of blood, the data for release into PPP indicated that the rate of S1P release into blood may actually be more similar to release into 0.4% FAF-BSA, possibly due to lipids already bound to the plasma albumin. This suggests that the availability of S1P binding sites on albumin (or other lipid carriers) in solution controlled the rate of release, perhaps simply by decreasing the concentration of free S1P at the gel/solution interface. Alternatively, if albumin in solution diffused into the hydrogel during the experiment, the increase in the rate of S1P release in higher concentrations of albumin solution may be transport of S1P through the gel by the diffusing albumin. In this case, the concentration of dissolved albumin in the gel would be a function of the concentration of albumin in solution and the diffusivity of albumin in the gel. However, modified SDS-PAGE indicated that the diffusion of albumin through the PEG-OVS/albumin gels is greatly restricted (Fig 2b) If the reaction of a diffusible molecule with an immobilized component is fast relative to the diffusion of the molecule, the diffusion coefficient is effectively lowered by a factor proportional to the fraction of the molecule that is unbound at equilibrium. Thus, , where R is a partition coefficient equal to [S1P-alb i ]/[S1P] and [S1P-alb i ] is the concentration of S1P bound to the gel. 41 The effective diffusion coefficient can be determined from S1P release data by equation 1, assuming the release solution is a perfect sink. In our system, the effective diffusion constant was found to be a function of the concentration of albumin in solution. While loading of S1P onto albumin in PPP, 0.4% and 4% FAF-BSA release solutions is far from equilibrium at every time point (see Supplementary Table 2 ), the S1P concentration gradient between the gel and solution is likely affected by the accumulation of S1P near the interface due to the lack of mixing in the release solution. In Supplementary Figure 1 , we show that the observed differences in effective diffusion coefficients for release into 0.4% and 4% FAF-BSA are explainable by differences in the concentration of free S1P at the boundary in unstirred solutions with K D on the order of 100 nM. The perfect sink condition is not achieved with 0.4 or 4% FAF-BSA; however, the error in this assumption is shown to be low for 4% FAF-BSA. Further measurements of the affinity of interactions between albumin for S1P, the rate of diffusion of albumin in the gels, or the amount of unreacted albumin in the gels will be needed to determine the mechanism of S1P release.
The biomaterials we developed may provide a new tool to promote healing and angiogenesis in ischemic tissue. By incorporating the lipid-transporter protein albumin into the hydrogels, the release of S1P was controlled by affinity interactions. The high concentration of albumin in the gels (10% w/v, 1.51 μM) allowed S1P to be efficiently loaded into the gels and slowly released, even into solutions containing high concentrations of lipid transporter proteins. We demonstrated that the S1P released from the hydrogels enhanced migration of endothelial cells growing on the materials, and induced angiogenesis in the CAM model. Further development of the materials with higher affinity lipid-transporting proteins, or enzymes that produce sphingosine 1-phosphate in situ, may lead to materials that are useful in promoting angiogenesis or the endothelialization of materials following implantation.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material. Synthesis of PEG-octavinylsulfone. PEG-octavinylsulfone was synthesized using a 4-step process from eight-arm PEG (mol. wt. 10,000). a) The percentage of endgroup conversion for each step in the PEG-octavinylsulfone synthesis was obtained by comparing the areas of endgroup peaks to the area of the PEG backbone peak. b) NMR of the PEG-octavinylsulfone product, with the PEG backbone peak at 3.61 ppm, and the vinyl sulfone peaks between 6 and 7 ppm. Characterization of Hydrogel Crosslink Densities. a) PEG-octavinylsulfone (PEG-OVS) or PEG-tetravinylsulfone (PEG-TVS) was crosslinked with albumin, fibrinogen, PEG-diamine (mol. wt. 3400), or DTT. The percent solid in each swollen gel was calculated after 4 days of swelling in PBS, pH 7.4. The hydrogels were crosslinked at the percent solids listed above each column. Data represent mean ± standard deviation. b) A 15% SDS-PAGE gel was polymerized, with a spacer on the top left side of the chamber. After the spacer was removed, a thin layer of PEG-OVS/albumin precursor solution was pipetted into the formed well and crosslinked for 24 h. A 7% SDS-PAGE gel was then polymerized to fill the rest of the casting chamber. Bovine serum albumin (BSA; 20 μg in 20 μL) was loaded on the gel at the indicated locations. BSA did not pass through the PEG gel and accumulated above the hydrogel layer. Note the intense staining of the PEG-OVS/albumin gel with Coomassie Blue and the apparent migration of some proteinaceous material from the PEG gel. S1P release from PEG hydrogels 'postloaded' with S1P. PEG hydrogels were formed by reacting PEG-OVS with albumin, fibrinogen or PEG-diamine. The crosslinked hydrogels were then 'postloaded' with S1P by incubation with 5 nmol S1P in 0.01% FAF-BSA for 24 h at 37°C (all FAF-BSA solutions were in PBS, pH 7.4). This was followed by 2 washes with PBS for 1 h, and a final wash with PBS for 24 h. a) The contents of the first 1 h PBS wash and the 24 h PBS wash were analyzed by thin layer chromatography for a PEG-OVS/PEG-diamine gel (Diam.) or a PEG-OVS/albumin gel (Alb.). b) After the PBS washes, the same gels were then incubated with a solution of 0.4% FAF-BSA in PBS. Lane 5 shows the control consisting of S1P dissolved in 0.4% FAF-BSA while lane 6 shows S1P dissolved in methanol. Note the difference in R f in the presence of FAF-BSA. c) Release of S1P from PEG-OVS/albumin hydrogels was measured using [ 32 P]S1P. In 24 h at 37°C, the 50 μL hydrogels sequestered 59.1 ± 3.1% of the S1P from a solution of 5 nmol S1P in 1.5 mL of 0.01% FAF-BSA. During the PBS washes, 6.9 ± 1.1% of the loaded S1P was released over 26 h. At time = 0 in the figure, 0.4% FAF-BSA was added to the gels, leading to the release of 46.6 ± 0.4% of the S1P in the hydrogel within 24 h. Error bars represent std. dev. A scrape wound assay was used to demonstrate the response of human umbilical vein endothelial cells to S1P released from the hydrogels. PEG-OVS/albumin gels (20 μL) postloaded with S1P increased the amount of cell migration into the wound area (p = 0.01 vs. medium with no gel, p = 0.02 vs. PEG-OVS/Albumin gels without S1P loading) to an extent similar to 100 nM S1P in medium (p = 0.03 vs. medium with no gel, p = 0.02 vs. PEG-OVS/ albumin gels without S1P loading). All other experimental conditions did not cause significant differences in cell migration into the wound area versus medium alone. In the column labels, '(S1P)' denotes S1P postloaded into the hydrogels. * Statistically significant difference vs. medium with no gel. † Statistically significant difference vs. PEG-OVS/albumin gels without S1P loading. Error bars represent SEM with statistical analysis by ANOVA and postprocessing with the Scheffe test. Angiogenic response observed in CAM assay. (a) As controls, S1P or bFGF were spotted onto Thermanox coverslips, air-dried, and placed face down onto the chick chorioallantoic membrane (CAM). A strong angiogenic response was elicited by 50 ng bFGF or 50 ng S1P (characterized by the curvature of large vessels toward the point of stimulus). (b) A 20 μL PEG-OVS/albumin hydrogel without S1P showed no angiogenic response. A PEG-OVS/PEGdiamine hydrogel loaded with 5 nmol S1P and washed with PBS for 26 h showed little or no angiogenic response. A PEG-OVS/albumin hydrogel loaded with 5 nmol S1P and washed with PBS for 26 h showed a moderate to strong angiogenic response. Results from two separate experiments are shown for each treatment. S1P release from PEG gels crosslinked with albumin 'preloaded' with S1P. S1P was dissolved in PBS containing 17.5% FAF-BSA (1 nmol S1P per mg of albumin). PEG hydrogels (50 μL) were formed in the wells of a 24-well plate by adding PEG-OVS to the albumin/S1P solution, with a total of 5 nmol S1P present in each gel. a) The rate of S1P release was measured using [ 32 P]S1P. Approximately 5% of the S1P in the hydrogel was released into the PBS washes over 26 h. The rate of S1P release increased with increasing concentrations of FAF-BSA in the release solution. Release of S1P into human platelet poor plasma was similar to release into PBS containing 0.4% FAF-BSA. Dashed lines connect data points, solid lines show least squares fits of the data to a solution of the unsteady diffusion equation (see text). A single Endothelial cell migration on PEG gels crosslinked with albumin 'preloaded' with S1P. S1P was dissolved into PBS containing 17.5% FAF-BSA (1 nmol S1P per mg of albumin). PEG hydrogels (50 μL) were formed in the wells of a 24-well plate by reacting PEG-OVS with the albumin/S1P solution, with 5 nmol S1P present in each gel. RGD peptide was also added to the gels to promote cell adhesion and spreading. The migration speed of individual HUVEC seeded on PEG/albumin hydrogels containing RGD peptide was measured in the presence or absence of S1P released from the gel. Delivery of S1P from the hydrogel increased the mean migration speed of the HUVEC from 19.2 ± 10.1 μm/h to 43.8 ± 15.7 μm/h, while addition of 100 nM S1P to the medium above HUVEC growing on the PEG hydrogel increased the mean migration speed to 30.2 ± 11.8 μm/h (p = 3×10 −10 , gel + S1P vs. gel w/o S1P; p = 0.0008, gel + S1P vs 100 nM S1P; p = 0.02, 100 nM S1P vs. gel w/o S1P). Error bars represent std. dev. Statistical analysis was by ANOVA with post-processing with the Scheffe test Table 1 Effective diffusion coefficients for S1P release from PEG-OVS/albumin hydrogels. S1P release data in Figure 6 (a) was least-squares fit to a solution of the unsteady diffusion equation (see text), fitting a single parameter, the effective diffusion coefficient. The release of [ 32 P]S1P from PEG-OVS/albumin gels was measured into 0%, 0.4%, and 4% FAF-BSA, as well as into platelet poor plasma (PPP). Additionally, coefficients of determination are reported for linear regressions of S1P release as a function of (time) 1 
